Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors
暂无分享,去创建一个
[1] J. Sehouli,et al. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high‐risk histopathological features, and lethal recurrence rates , 2016, BJOG : an international journal of obstetrics and gynaecology.
[2] T. Fehm,et al. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study , 2015, British Journal of Cancer.
[3] E. Darai,et al. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors. , 2014, American journal of obstetrics and gynecology.
[4] T. Fehm,et al. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] E. Darai,et al. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] L. Horn,et al. Neue FIGO-Klassifikation des Ovarial-, Tuben und primären Peritonealkarzinoms , 2014, Der Pathologe.
[7] O. Mogensen,et al. The Value of Random Biopsies, Omentectomy, and Hysterectomy in Operations for Borderline Ovarian Tumors , 2014, International Journal of Gynecologic Cancer.
[8] T. Fehm,et al. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. , 2013, European journal of cancer.
[9] P. Morice,et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. , 2013, Human reproduction update.
[10] M. Torella,et al. Borderline ovarian tumors: features and controversial aspects. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[11] J. Raduà,et al. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor , 2013, World Journal of Surgical Oncology.
[12] M. Zikan,et al. Diagnosis, treatment, and follow-up of borderline ovarian tumors. , 2012, The oncologist.
[13] H. Höfler,et al. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. , 2012, Gynecologic oncology.
[14] N. Biglia,et al. Clinical Significance of Microinvasion in Borderline Ovarian Tumors and Its Impact on Surgical Management , 2012, International Journal of Gynecologic Cancer.
[15] B. Davidson,et al. Borderline ovarian tumours. , 2012, Best practice & research. Clinical obstetrics & gynaecology.
[16] E. Darai,et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. , 2012, The Lancet. Oncology.
[17] P. Harter,et al. Borderline Tumors of the Ovary: Clinical Course and Prognostic Factors , 2012, Oncology Research and Treatment.
[18] Yong-Man Kim,et al. Micropapillary pattern in serous borderline ovarian tumors: does it matter? , 2011, Gynecologic oncology.
[19] A. Bois,et al. Borderline-Tumoren des Ovars – eine systematische Übersicht , 2009 .
[20] P. Neven,et al. Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] E. Suh-Burgmann. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. , 2006, Gynecologic oncology.
[22] A. Malpica,et al. The Recurrence and the Overall Survival Rates of Ovarian Serous Borderline Neoplasms With Noninvasive Implants is Time Dependent , 2006, The American journal of surgical pathology.
[23] J. McKenney,et al. Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up , 2005, The American journal of surgical pathology.
[24] J. Prat,et al. Serous Borderline Tumors of the Ovary: A Long-Term Follow-Up Study of 137 Cases, Including 18 With a Micropapillary Pattern and 20 With Microinvasion , 2002, The American journal of surgical pathology.
[25] K. Lu,et al. Clinical management of borderline ovarian tumors , 2000 .
[26] R. Kurman,et al. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. , 2000, Human pathology.
[27] T. Helleday,et al. The results of conservative (fertility-sparing) treatment in borderline ovarian tumors vary depending on age and histological type , 2014 .
[28] L. Horn,et al. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer]. , 2014, Der Pathologe.
[29] Antonio Malvasi,et al. Conservative surgery for borderline ovarian tumors: a review. , 2006, Gynecologic oncology.